Home » News » Nephrology » End-Stage Renal Disease
End-Stage Renal Disease
Beyond mean hemoglobin A1c, glycemic variability over time may be an additional risk factor for poor kidney outcomes.
In a study, patients undergoing thrice-weekly extended home hemodialysis had a lower death risk compared with those receiving in-center conventional hemodialysis.
Empagliflozin is a sodium-glucose co-transporter 2 inhibitor.
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events, and mortality in patients on hemodialysis.
Incorporating a combination of urinary biomarkers may help identify patients at the highest risk for CKD progression.
A small study showed that 38% of patients with ANCA-glomerulonephritis vasculitis who underwent for-cause repeat biopsy had active disease.
Preeclampsia is an important risk factor for chronic kidney disease and warrants post-delivery monitoring, according to investigators.
Acute kidney injury did not necessarily explain the study results.
The Kidney Cancer Risk Equation for predicting post-nephrectomy ESKD builds on the ubiquitous Kidney Failure Risk Equation and is easy to use, according to investigators.
Study finds age-, sex-, race and ethnicity-, and social deprivation-related disparities in the timing of preoperative hemodialysis.
Load More
Open
Next post in End-Stage Renal Disease
Close
Close more info about Kidney Function That Seemingly Normalizes in Hospital Portends Adverse Outcomes
Loading...
Close more info about Kidney Function That Seemingly Normalizes in Hospital Portends Adverse Outcomes
Loading...